JPRN-UMIN000005608已完成2 期
Weekly Paclitaxel in Combination with Bevacizumab in Patients with Non-Squamous Non-Small Cell Lung Cancer Who Have Failed Previous Treatments-Phase II study- - Weekly Paclitaxel in Combination with Bevacizumab in Patients with Non-Squamous Non-Small Cell Lung Cancer Who Have Failed Previous Treatments-Phase II study
Division of Medical Oncology and Molecular Respirology Department of Multidisciplinary Internal Medicine Faculty of Medicine, Tottori University0 个研究点目标入组 31 人开始时间: 2011年5月23日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 31
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)Received transfusion or G-CSF within 14 days prior to enrollment (2)Urine protein>=2+ (3)History of drug allergy (4)Active multiple cancers (5)Severe infection (6)High fever (7)Abnormal cardiac function (8)Severe pulmonary disease; Interstitial pneumonia, severe COPD, pulmonary thromboembolism (9)Need for drainage of pleural effusion, acsites or pericardial effusion (10)History of hematoemesis, ileus and gastroduodenal ulcer (11)symptomatic CNS metastases (12)CNS or Psychological disorders (13)Medically uncontrolled hypertension or diabetes mellitus (14)Nonhealing wound and surgery within 4 weeks before treatment (15)History of hemoptysis; one-half teaspoon of bright red blood per event (16)Therapeutic anticoagulation(full-dose therapeutic anticoagulation current and recent use of aspirin (>=325 mg/day) (17)severe bone marrow suppression (18)Pregnancy or lactation
研究者
相似试验
已完成
2 期
Weekly Paclitaxel in Combination with Bevacizumab in Patients with Non-Squamous Non-Small Cell Lung Cancer Previously Untreated -A Phase II studyPatients with non-squamous non-small cell lung cancer previously untreatedJPRN-UMIN000014345Division of Medical Oncology and Molecular Respirology, Faculty of Medicine, Tottori University36
已完成
2 期
Weekly paclitaxel in combination with bevacizumab in patient with HER2 nagative breast cancer who were previously treated with taxane - PhaseIIHER2 negative breast cancerJPRN-UMIN000009582Setouchi Breast Project Comprehensive Support Organization33
招募中
4 期
Observational study of paclitaxel with Bevacizumab for advanced or recurrent breast cancer(SBCCSG-28)advanced or recurrent breast cancerJPRN-UMIN000009090Saitama Breast Cancer Clinical Study Group (SBCCSG)70
已完成
1 期
Weekly Paclitaxel/Carboplatin/Bevacizumab as First Line Therapy for Triple Negative Breast CancerBreast CancerNCT00691379Hellenic Oncology Research Group46
已完成
2 期
A phase II study of Bevacizumab plus Paclitaxel followed by Eribulin maintenance therapy in patients with HER2-negative metastatic breast cancer.HER2-negative metastatic breast cancerJPRN-UMIN000015971Sairtama Breast Cancer Clinical Study Group (SBCCSG)51